Archive for the ‘Buprenorphine’ Category

Upcoming Webinar Trainings on PCSS-B

October 15th, 2010

Physicians’ Clinical Support System- Buprenorphine will be hosting webinars on the second Tuesday of every month,         12:00 – 1:00 Eastern time. 

November 9, 2010
Drug Enforcement Agency – presented by Cathy A. Gallagher, Associate Chief, Liaison and Policy Section, DEA

December 14, 2010
Treating Opioid Dependence in Pregnant Women – presented by Hendree Jones, PhD, Research Director, Center for Addiction and Pregnancy, Johns Hopkins Bayview Medical Center

January 11, 2011
Detoxification: Terminable or Interminable – presented by Herbert D. Kleber, MD, Professor of Psychiatry, Columbia University and Director, Division of Substance Abuse, New York State Psychiatric Institute

For more details on these trainings, click here.

Posted in Buprenorphine, News & Updates

Abstinence Rates with Office-based Buprenorphine Treatment Differ by Retention and Insurance Status

March 4th, 2010

As office-based treatment of opioid dependence with buprenorphine becomes more widespread, an increasing number of reports describe practices and outcomes in real-world settings. This report describes a highly structured office-based program that included a 1—2 day inpatient induction, 5 weeks of 3-hour counseling sessions 4 times per week, then weekly counseling sessions for an additional 12 weeks. Participants attended subsequent monthly follow-up visits and were required to attend thrice weekly 12-step meetings. Full adherence was required to remain in the program. Among the 110 of 176 (63%) consecutively admitted patients available for follow-up at a minimum of 18 months.

Published In: Alcohol, Other Drugs, and Health: Current Evidence a project of the Boston Medical Center issue November/December 2009. Access checked 1/10/10. Hillary Kunins, MD, MPH, MS

Posted in Buprenorphine

A Case For Health Care Reform

September 24th, 2009

Medical Costs and Unrecognized/Untreated for Substance Use Disorders: A Case for Health Care Reform Fact Sheet

Posted in Buprenorphine, Opioid Treatment Programs


A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.